Linden Thomas Advisory Services LLC Acquires 517 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Linden Thomas Advisory Services LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,920 shares of the medical equipment provider’s stock after acquiring an additional 517 shares during the period. Linden Thomas Advisory Services LLC’s holdings in Intuitive Surgical were worth $1,997,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Vanguard Group Inc. grew its position in Intuitive Surgical by 0.7% during the third quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock valued at $8,730,184,000 after acquiring an additional 196,316 shares during the last quarter. Jennison Associates LLC grew its position in Intuitive Surgical by 6.4% during the third quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock valued at $1,340,205,000 after acquiring an additional 274,692 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Intuitive Surgical by 6.6% during the third quarter. Invesco Ltd. now owns 3,750,490 shares of the medical equipment provider’s stock valued at $1,096,231,000 after purchasing an additional 232,205 shares during the period. Northern Trust Corp boosted its stake in shares of Intuitive Surgical by 3.4% during the third quarter. Northern Trust Corp now owns 3,514,421 shares of the medical equipment provider’s stock valued at $1,027,230,000 after purchasing an additional 115,059 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Intuitive Surgical by 0.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,030,415 shares of the medical equipment provider’s stock valued at $593,470,000 after purchasing an additional 17,477 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares in the company, valued at $9,373,093.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares in the company, valued at $9,373,093.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the transaction, the senior vice president now owns 1,842 shares of the company’s stock, valued at $736,800. The disclosure for this sale can be found here. Insiders sold 248,418 shares of company stock worth $95,927,097 over the last three months. 0.80% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on ISRG shares. Royal Bank of Canada increased their price objective on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. Truist Financial increased their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Mizuho increased their price objective on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Thursday, January 25th. BTIG Research increased their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research note on Friday. Finally, StockNews.com lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $396.17.

Intuitive Surgical Trading Up 2.1 %

ISRG traded up $7.75 during trading on Tuesday, reaching $376.68. The stock had a trading volume of 1,071,456 shares, compared to its average volume of 1,666,347. The stock’s 50 day moving average is $386.57 and its two-hundred day moving average is $344.41. The company has a market capitalization of $133.51 billion, a price-to-earnings ratio of 68.22, a P/E/G ratio of 5.69 and a beta of 1.36. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.00 earnings per share. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.